Publications in collaboration with researchers from Centro de Investigación Biomédica en Red de Cáncer (2)

2022

  1. In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria

    Molecular Therapy - Methods and Clinical Development, Vol. 25, pp. 137-146